A phase I/II trial of ganetespib in combination with paclitaxel and trastuzumab in HER2-positive breast cancer and ganetespib in combination with paclitaxel in triple negative breast cancer
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 22 Feb 2012
At a glance
- Drugs Ganetespib (Primary) ; Paclitaxel; Trastuzumab
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- 22 Feb 2012 Preliminary results are expected by the end of 2012, according to a Synta Pharmaceuticals media release.
- 22 Feb 2012 Planned initiation date changed from 1 Dec 2012 to 1 Mar 2012.
- 22 Feb 2012 Status changed from planning to not yet recruiting.